| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9589 |
| Human Intestinal Absorption | HIA- | 0.9280 |
| Caco-2 Permeability | Caco2- | 0.7063 |
| P-glycoprotein Substrate | Non-substrate | 0.8965 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9803 |
| Non-inhibitor | 0.9935 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9579 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7883 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8174 |
| CYP450 2D6 Substrate | Non-substrate | 0.8424 |
| CYP450 3A4 Substrate | Non-substrate | 0.7190 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9059 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9074 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9281 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8957 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9403 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9818 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8544 |
| Non-inhibitor | 0.9647 |
| AMES Toxicity | Non AMES toxic | 0.9349 |
| Carcinogens | Carcinogens | 0.6524 |
| Fish Toxicity | Low FHMT | 0.8708 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7214 |
| Honey Bee Toxicity | High HBT | 0.8148 |
| Biodegradation | Ready biodegradable | 0.6862 |
| Acute Oral Toxicity | III | 0.7952 |
| Carcinogenicity (Three-class) | Non-required | 0.5719 |